Schedule 13G ownership disclosure

Rhythm Pharmaceuticals Inc

Security class unavailable · CUSIP: 76243J105

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,240,153
Percent of class
2.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-23-000026
Form type
SC 13G/A
Filer
Janus Henderson Group Ltd.
CIK
CIK 1274173
Filed
Feb 09, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub